A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy.
Erdoğan Selçuk ŞeberYakup İriağaçEyyüp CavdarKubilay KaraboyunOkan AvcıAhmet YolcuSibel Özkan GürdalMeltem ÖznurPublished in: Revista da Associacao Medica Brasileira (1992) (2023)
In hormone receptor-positive breast cancer patients receiving neoadjuvant chemotherapy, the logarithmic model has been shown in a larger patient population to be an inexpensive, easy, and rapidly applicable predictive marker that can be used to predict response.